B. A. Naaijkens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
B. A. Naaijkens has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
A. van Dijk
VU University Medical Center
1 shared publication- Hans W. M. Niessen
Department of Pathology and Department of Cardiac Surgery, Institute for Cardiovascular Research, Amsterdam University Medical Center, 1007 MB Amsterdam, Netherlands
1 shared publication L. J. M. Juffermans
VU University Medical Center
1 shared publication- Otto Kamp
Department of Cardiology, Amsterdam University Medical Center , Amsterdam
1 shared publication - Paul A. J. Krijnen
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands
1 shared publication
Latest Publications
- 1 March 2014
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 10 (3) , 389-398
Therapeutic Application of Adipose Derived Stem Cells in Acute Myocardial Infarction: Lessons from Animal Models
The majority of patients survive an acute myocardial infarction (AMI). Their outcome is negatively influenced by post-AMI events, such as loss of viable cardiomyocytes due to a post-AMI inflammatory response, eventually resulting in heart failure and/or death. Recent pre-clinical animal studies indicate that mesenchymal stem cells derived from adipose tissue (ASC) are new promising candidates that may facilitate cardiovascular regeneration in the infarcted myocardium. In this review we have compared all animal studies in which ASC were used as a therapy post-AMI and have focused on aspects that might be important for future successful clinical application of ASC.
- 1 March 2014
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 10 (3) , 389-398
Therapeutic Application of Adipose Derived Stem Cells in Acute Myocardial Infarction: Lessons from Animal Models
The majority of patients survive an acute myocardial infarction (AMI). Their outcome is negatively influenced by post-AMI events, such as loss of viable cardiomyocytes due to a post-AMI inflammatory response, eventually resulting in heart failure and/or death. Recent pre-clinical animal studies indicate that mesenchymal stem cells derived from adipose tissue (ASC) are new promising candidates that may facilitate cardiovascular regeneration in the infarcted myocardium. In this review we have compared all animal studies in which ASC were used as a therapy post-AMI and have focused on aspects that might be important for future successful clinical application of ASC.